Loading
Latest filing published 13 Nov 2024 for Coya Therapeutics, Inc., €35k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Arun Swaminathan on record concern Coya Therapeutics, Inc. Between 11 November 2024 and 13 November 2024, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €69k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 13 November 2024: an open-market purchase of €35k, in Coya Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations